These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 31565143

  • 1. Frequency of maintenance hemodialysis patients meeting K/DOQI criteria for serum calcium, phosphorus, calcium phosphorus product and PTH levels; a single institutional experience from Pakistan: a cross sectional study.
    Janjua TK, Mukhtar KN, Naveed AK, Ahmed EB, Rehan M.
    Pan Afr Med J; 2019; 33():183. PubMed ID: 31565143
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C, Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.
    J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Consequences of the implementation of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease in a population of patients on chronic hemodialysis.
    Arenas MD, Alvarez-Ude F, Torregrosa V, Gil MT, Carretón MA, Moledous A, Nuñez C, Devesa R, Albiach B.
    J Nephrol; 2007; 20(4):453-61. PubMed ID: 17879212
    [Abstract] [Full Text] [Related]

  • 6. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
    Lucchi L, Carboni C, Stipo L, Malaguti V, Ferrari F, Graziani R, Arletti S, Graziosi C.
    Artif Organs; 2011 Dec; 35(12):1186-93. PubMed ID: 21848793
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millán I, Amoedo ML, Muray S, Carretón MA.
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between pruritus and serum concentrations of parathormone, calcium and phosphorus in hemodialysis patients.
    Tajbakhsh R, Joshaghani HR, Bayzayi F, Haddad M, Qorbani M.
    Saudi J Kidney Dis Transpl; 2013 Jul; 24(4):702-6. PubMed ID: 23816717
    [Abstract] [Full Text] [Related]

  • 16. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study.
    Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi T, Fukuhara S, Akizawa T, Saito A, Asano Y, Kurokawa K, Pisoni RL, Port FK.
    Hemodial Int; 2007 Jul; 11(3):340-8. PubMed ID: 17576300
    [Abstract] [Full Text] [Related]

  • 17. [CA-P control in haemodialysis and K/DOQI guidelines].
    Rivera F, Sánchez de la Nieta MD, Echarri R, Anaya S, Carreño A, Vozmediano MC, Alcaide MP.
    Nefrologia; 2006 Jul; 26(3):351-7. PubMed ID: 16892824
    [Abstract] [Full Text] [Related]

  • 18. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M.
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
    Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M.
    Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
    [Abstract] [Full Text] [Related]

  • 20. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
    Hoy T, Fisher M, Barber B, Borker R, Stolshek B, Goodman W.
    Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.